AWARE: A Week of Addiction and Recovery Education

April 24-28, 2017

“We must help everyone see that addiction is not a character flaw – it is a chronic illness that we must approach with the same skill and compassion with which we approach heart disease, diabetes, and cancer.”   

– Dr. Vivek H. Murthy, MD/MBA, United States Surgeon General

From the 2016 Surgeon General’s Report on Alcohol, Drugs, and Health, “substance use disorders are one of the most pressing public health crises of our generation.” Scientific advances show addiction is a complex disease shaped by both neurobiology and experience that cannot be viewed without the lens of the social determinants of health. To that end, there is still much for physicians and trainees to learn. The AMSA Medical Education Team and the Action Committee for Community and Public Health believe patients suffering from substance use disorders deserve the same degree of respect, dignity, and attention as any other segment of society.

The mission for AWARE: A Week of Addiction and Recovery Education is to:

  • Raise awareness about substance misuse and abuse as a public health priority
  • Instill a compassionate, total health approach to care that is free of stigma and based in evidence
  • Explore current themes and models of prevention, treatment, and recovery
  • Cultivate the knowledge, skills, and attitudes for community engagement and improvement
AWARE: Week of Action
4/24/2017 – 4/28/2017 | Online
          PROGRAM THEMES:           
The Opioid Epidemic
Harm Reduction and Treatment
Managing Stigma and Professionalism
Substance Abuse in Healthcare
Examining Abstinence and Anonymity
Addiction Advocacy


Thank you for joining us for 2017’s ‘A Week of Addiction and Recovery Education’ and for making the event a huge success!

AWARE: A Week of Addiction and Recovery Education Event Details

Monday, April 24, 2017 at 6:00pm ET
Prescription Opioid Abuse in Healthcare Providers and Proper Prescribing Practices

Dr. Stephen Loyd
Medical Director, Substance Abuse Services
Tennessee Department of Mental Health and Substance Abuse Services

Dr. Stephen Loyd, MD is the Medical Director of Substance Abuse Services for the Tennessee Department of Mental Health and Substance Abuse Services and an Associate Professor for the Department of Internal Medicine at East Tennessee State University Quillen College of Medicine. Dr. Loyd is in long-term recovery from addiction to opiates, benzodiazepines, and alcohol since July 2004, and now serves as a speaker for substance abuse among healthcare providers and the proper prescribing of controlled substances. He was a founding partner of “High Point Clinic” in Johnson City, TN, the only 501(c)3 not-for-profit medication assisted treatment clinic prescribing buprenorphine in the state of Tennessee with special interest in opiate addicted pregnant women. He has served as an expert witness in malpractice cases for the TBI, FBI, DEA, and IRS among many other institutions, and was named the 2014 Advocate for Action at the Office of National Drug Control Policy through the Executive Office of the President of the United States. Dr. Loyd continues working in the public health arena to advocate for evidence based approaches to treating addiction as a disease, and as a long time professor is dedicated to educating medical students and trainees about addiction medicine.

Learn more about Dr. Stephen Loyd’s story in an article run in The New Physician magazine titled “Patient, Not Pariah: Shifting the Approach to Addictive Disease” written by Daniel H. Gouger.

Tuesday, April 25, 2017 at 6:00pm ET
Q&A with the Experts: How the Opioid Epidemic Impacts Women

Dr. Vance Shaw, MD
Addiction Medicine Specialist
Chief Medical Officer, “High Point Clinic,” an evidence based addiction treatment facility

Dr. Vance Shaw is an assistant professor at East Tennessee State University Quillen College of Medicine who has been board certified in Addiction Medicine for over twelve years. He serves as the Chief Medical Officer of “High Point Clinic” in Johnson City, TN, the only 501(c)3 not-for-profit medication assisted treatment clinic prescribing buprenorphine in the state of Tennessee. Prior to practicing solely as an addiction medicine specialist, Dr. Shaw was boarded in Family Medicine and practiced rural primary care. Dr. Shaw and his clinic particularly focus on the treatment and maintenance of opioid addicted pregnant women by utilizing a multitude of interprofessional wrap-around services including board certified physicians and addiction medicine specialists, licensed professional social workers, masters level counselors who conduct both individual and group therapy, and case managers. He works regularly with his team to advocate for evidence based treatment of addiction through educating healthcare providers and trainees on treatment methodologies and long-term recovery strategies, as well as dissolving systemic stigma and bias toward patients suffering from substance abuse disorders. He and his clinic also collaborate with grassroots organizing groups advocating for evidence based policies and legislation that work toward both substance abuse prevention and harm reduction, and improved comprehensive mental health.

Marjorie Jenkins, M.D., M.Ed.H.P., F.A.C.P.
Director of Medical Initiatives and Scientific Engagement
FDA Office of Women’s Health

Dr. Jenkins Headshot
Dr. Jenkins serves at the FDA Office of Women’s Health (OWH) as Director of Medical Initiatives and Scientific Engagement and also as a tenured Professor of Medicine, Founding Director and Chief Scientific Officer for the Laura W. Bush Institute for Women’s’ Health and at Texas Tech University Health Sciences Center. Prior to her career in medicine she received a degree in Chemical Engineering. In addition, Dr. Jenkins completed a Masters in Education for Health Professionals at Johns Hopkins University. Dr. Jenkins translational research focus is in the area of cancer immunotherapy where she worked with an NIH-funded team developing ovarian cancer vaccines and incorporation of sex differences into the cancer immunotherapy platform. She is a leader in women’s health and sex and gender medicine has served nationally in a variety of positions, such as Program Chair of the 2015 and 2018 National Sex and Gender Medical Education Summit, co-Chair of the Reproduction Workgroup of NASA’s Decadal Review of Sex and Gender Research, a member of the Women’s Health Writing Group of the National Board of Medical Examiners, and HRSA and NIH expert panel advisories. She has published extensively in both the scientific and lay press.

Wednesday, April 26, 2017 at 8:00pm ET
CDC’s Prevention Efforts to Address the Prescription Opioid Epidemic

Dr. Christina Mikosz, MD, MPH
Medical Officer in the Division of Unintentional Injury Prevention
Centers for Disease Control and Prevention

Christina Mikosz photoDr. Christina Mikosz serves as a Medical Officer on the Prescription Drug Overdose Health Systems team in the Division of Unintentional Injury Prevention at the Centers for Disease Control and Prevention. Her primary research interest as a medical epidemiologist is in healthcare quality improvement, an interest she has explored working at both federal and county public health systems. In her current role, Dr. Mikosz is involved in a number of projects related to the follow-up study and implementation of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain and also provides technical expertise to states to support ongoing overdose prevention work. Prior to her current position at CDC, Dr. Mikosz worked in two different county public health departments in California. She previously served as an Epidemic Intelligence Service Officer with CDC and also worked as a staff hospitalist at the University of California, San Francisco. Dr. Mikosz completed medical school at Rush Medical College and internship/residency in Internal Medicine at the University of California, San Francisco.

Thursday, April 27, 2017 at 5:30pm ET
Addiction Medicine as a Subspecialty and In Practice

Co-hosted by the American Society of Addiction Medicine (ASAM)

R. Corey Waller, MD, MS
Senior Medical Director for Education and Policy
Camden Coalition of Healthcare Providers

R Corey WallerCorey Waller MD, MS is an addiction, pain, and emergency medicine specialist in Grand Rapids, MI. He works within the Spectrum Health system, a fully integrated health system with 11 hospitals and over 1000 employed physicians. He is the Medical Director of the Spectrum Health Medical Group Center for Integrative Medicine, the Medical Staff Chief of Pain Medicine to the Spectrum Health Hospital System, the President of the Michigan Society of Addiction Medicine, as well as SUD Medical Director at Lakeshore Regional Partners (Community Mental Health-Region 3). Dr. Waller earned a Masters of Science in neuromolecular biology at Southwest Texas State University and earned his Medical Degree at the University of Texas Medical School in San Antonio. Dr. Waller completed his Emergency Medicine residency at Thomas Jefferson University in Philadelphia. Dr. Waller’s special interests include understanding the biopsychosocial and financial impact of high cost complex patients, pregnant patients with a substance use disorder, and the complex interaction of pain and addiction.

Anne Marie Williams
Fourth-Year Medical Student
Harvard Medical School

Anne Marie Williams is a fourth year medical student graduating from Harvard Medical School in May and beginning Family Medicine residency in Seattle, WA. She is passionate about treating substance use disorders in primary care and, as a member of the Massachusetts Student Coalition on Addiction has advocated for more primary care doctors to provide office-based medication assisted treatment for opioid addiction.